The PDZ protein TIP-1 facilitates cell migration and pulmonary metastasis of human invasive breast cancer cells in athymic mice

Biochemical and Biophysical Research Communications

Volumn 422, Issue 1, 2012, Pages 139-145

  Han, Miaojun ^a,b,c   Wang, Hailun ^c   Zhang, Hua Tang ^a   Han, Zhaozhong ^c,d  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Beta catenin; Breast cancer; Cell adhesion; Migration; Pulmonary metastasis; Tax interacting protein 1

Indexed keywords

BETA CATENIN; FIBRONECTIN; INTEGRIN; PAXILLIN; PDZ PROTEIN; TAX INTERACTING PROTEIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FIBRONECTINS; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PDZ DOMAINS; RNA INTERFERENCE;

MUS;

EID: 84861461944     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.04.123     Document Type: Article

References (27)

1. Polakis P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 2012, 12.
2. Geyer F.C., Lacroix-Triki M., Savage K., Arnedos M., Lambros M.B., MacKay A., Natrajan R., Reis-Filho J.S. Beta-catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mod. Pathol. 2011, 24:209-231.
3. Wang X., Goode E.L., Fredericksen Z.S., Vierkant R.A., Pankratz V.S., Liu-Mares W., Rider D.N., Vachon C.M., Cerhan J.R., Olson J.E., Couch F.J. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2008, 17:2101-2108.
4. Khramtsov A.I., Khramtsova G.F., Tretiakova M., Huo D., Olopade O.I., Goss K.H. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol. 2010, 176:2911-2920.
5. Besser J., Leito J.T., van der Meer D.L., Bagowski C.P. Tip-1 induces filopodia growth and is important for gastrulation movements during zebrafish development. Dev. Growth Differ. 2007, 49:205-214.
6. Dev K.K. Making protein interactions druggable: targeting PDZ domains. Nat. Rev. Drug Discov. 2004, 3:1047-1056.
7. Reynaud C., Fabre S., Jalinot P. The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element. J. Biol. Chem. 2000, 275:33962-33968.
8. Olalla L., Aledo J.C., Bannenberg G., Marquez J. The C-terminus of human glutaminase L mediates association with PDZ domain-containing proteins. FEBS Lett. 2001, 488:116-122.
9. Alewine C., Olsen O., Wade J.B., Welling P.A. TIP-1 has PDZ scaffold antagonist activity. Mol. Biol. Cell 2006, 17:4200-4211.
10. Cui H., Hayashi A., Sun H.-S., Belmares M.P., Cobey C., Phan T., Schweizer J., Salter M.W., Wang Y.T., Tasker R.A., Garman D., Rabinowitz J., Lu P.S., Tymianski M. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors. J. Neurosci. 2007, 27:9901-9915.
11. Rousset R., Fabre S., Desbois C., Bantignies F., Jalinot P. The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 1998, 16:643-654.
12. Hampson L., Li C., Oliver A.W., Kitchener H.C., Hampson I.N. The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. Int. J. Oncol. 2004, 25:1249-1256.
13. Obenauer J.C., Denson J., Mehta P.K., Su X., Mukatira S., Finkelstein D.B., Xu X., Wang J., Ma J., Fan Y., Rakestraw K.M., Webster R.G., Hoffmann E., Krauss S., Zheng J., Zhang Z., Naeve C.W. Large-scale sequence analysis of avian influenza isolates. Science 2006, 311:1576-1580.
14. Kanamori M., Sandy P., Marzinotto S., Benetti R., Kai C., Hayashizaki Y., Schneider C., Suzuki H. The PDZ protein Tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells. J. Biol. Chem. 2003, 278:38758-38764.
15. Wang H., Yan H., Fu A., Han M., Hallahan D., Han Z. TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation. PLoS One 2010, 5:e12051.
16. Han Z., Fu A., Wang H., Diaz R., Geng L., Onishko H., Hallahan D.E. Noninvasive assessment of cancer response to therapy. Nat. Med. 2008, 14:343-349.
17. Cheng A.S., Culhane A.C., Chan M.W., Venkataramu C.R., Ehrich M., Nasir A., Rodriguez B.A., Liu J., Yan P.S., Quackenbush J., Nephew K.P., Yeatman T.J., Huang T.H. Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome. Cancer Res. 2008, 68:1786-1796.
18. Zhao H., Langerod A., Ji Y., Nowels K.W., Nesland J.M., Tibshirani R., Bukholm I.K., Karesen R., Botstein D., Borresen-Dale A.L., Jeffrey S.S. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell 2004, 15:2523-2536.
19. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
20. Wang Y., Shenouda S., Baranwal S., Rathinam R., Jain P., Bao L., Hazari S., Dash S., Alahari S.K. Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis. Mol. Cancer 2011, 10:84.
21. Alewine C., Kim B.Y., Hegde V., Welling P.A. Lin-7 targets the Kir2.3 channel on the basolateral membrane via a L27 domain interaction with CASK. Am. J. Physiol. Cell Physiol. 2007, 293:C1733-C1741.
22. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
23. Oliver A.W., He X., Borthwick K., Donne A.J., Hampson L., Hampson I.N. The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br. J. Cancer 2011, 104:324-331.
24. Wang C., Yoo Y., Fan H., Kim E., Guan K.L., Guan J.L. Regulation of Integrin beta 1 recycling to lipid rafts by Rab1a to promote cell migration. J. Biol. Chem. 2010, 285:29398-29405.
25. Bishop A.L., Hall A. Rho GTPases and their effector proteins. Biochem. J. 2000, 348(Pt 2):241-255.
26. Zhang J., Yan X., Shi C., Yang X., Guo Y., Tian C., Long J., Shen Y. Structural basis of beta-catenin recognition by Tax-interacting protein-1. J. Mol. Biol. 2008, 384:255-263.
27. Jeanes A., Gottardi C.J., Yap A.S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression?. Oncogene 2008, 27:6920-6929.